glp-1 and dementia receptor agonists effect on cognitive function in patients with without type 2 diabetes What's Next for Alzheimer's Treatment?
Description
During the 1970s the pharmaceutical company Glaxo has poured a lot of investment into the development of CCK because it had been shown to suppress appetite in rodents
:max_bytes(150000):strip_icc()/VWH-How-could-GLP-1s-impact-dementia-AD-FINAL-a0c8263ef12141919ca453be8a96d22b.jpg)
JPTs Diabetes Peptide%3b GLP-1 receptor agonists Glucagon-like Peptide 1 (GLP-1) and other GLP-1 receptor agonists have proven to be an effective treatment of Type 2 diabetes and obesity, offering significant benefits
"Eli Lilly is a great company
Lancet Diabetes Endocrinol 2019;7:35667
